Last reviewed · How we verify
NCT06956417: REMEMBR
REhabilitation of MEMory Symptoms After BRain Concussion
NA trial testing Cognitive behavioral therapy in Concussion, Brain in 184 participants. Currently enrolling.
30 April 2028
Quick facts
| Lead sponsor | University of British Columbia |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | treatment |
| Enrollment | 184 |
| Start date | 2 July 2025 |
| Primary completion | 30 April 2028 |
| Estimated completion | 30 April 2029 |
| Sites | 9 locations across Canada |
Drugs / interventions tested
- Cognitive behavioral therapy
- Cognitive rehabilitation
Conditions studied
- Concussion, Brain — all drugs for Concussion, Brain →
- Mild Traumatic Brain Injury — all drugs for Mild Traumatic Brain Injury →
Sponsor
University of British Columbia
Who can join
Adults 18 to 59, any sex, with Concussion, Brain or Mild Traumatic Brain Injury. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Persistent memory symptoms after concussion are common, and likely perpetuated by unhelpful illness beliefs and coping behaviors. Results from a pilot study suggested that traditional cognitive rehabilitation and a novel cognitive-behavioral therapy (CBT) protocol were both associated with improvements in subjective memory functioning. The present study will more definitively compare the effectiveness of these interventions for improving subjective memory functioning after concussion.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06956417
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Cognitive behavioral therapy
Trials testing the same drug.
- NCT06866639 — Cognitive Behavioural Therapy/Metacognitive Therapy for Low Self Esteem · NA · not yet recruiting
- NCT06511518 — Cognitive Behavioral Therapy for Cancer-related Fatigue in Patients With Cancer Receiving Palliative Systemic Treatment · NA · recruiting
- NCT06189534 — Cognitive Behavior Therapy for Social Media Addiction, Insomnia, and Family Relationship Among Individuals With Social M · NA · unknown
- NCT06174350 — Evaluation of the Effect of Cognitive Behavioral Therapy in Individuals Exposed to Earthquakes · NA · unknown
- NCT05227612 — Psilocybin-assisted CBT for Depression · Phase 1 · completed
Other recruiting trials for Concussion, Brain
Currently open trials in the same condition.
- NCT06739785 — Turkish Translation of SportsConcussion Assesment Tool 6 · active not recruiting
- NCT06270290 — The COSP-RBD Study: Concussions and Contact Sports in RBD vs Controls · recruiting
- NCT06208813 — Creatine Supplementation in Concussion Recovery · NA · recruiting
- NCT06036147 — Concussion Health Improvement Program · NA · recruiting
- NCT05682677 — Combined Neuromodulation and Cognitive Training for Post-mTBI Depression · NA · recruiting
Other University of British Columbia trials
Trials by the same sponsor.
- NCT07340970 — Sensory Stimuli During Cesarean Delivery · not yet recruiting
- NCT07481201 — Phenylalanine Requirements in the Menstrual Phases · NA · not yet recruiting
- NCT07492095 — Leucine Requirements in School-Age Children · NA · not yet recruiting
- NCT07429305 — Combined Tibial Nerve Stimulation and Standing for People With SCI · NA · recruiting
- NCT07519928 — Exploring the Feasibility and Benefits of Implementing Pelvic Floor Muscle Training During Inpatient Rehabilitation for · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06956417 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of British Columbia
- Last refreshed: 30 July 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06956417.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing